Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemia and familial combined hyperlipidemia: correlation with high density lipoproteins.

OBJECTIVES This study sought to evaluate the extent of atherosclerosis in coronary and iliac arteries in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia, using intravascular ultrasound imaging. BACKGROUND Intravascular ultrasound imaging provides cross-sectional tomographic views of the vessel wall and allows quantitative assessment of atherosclerosis. METHODS Forty-eight nonsmoking, asymptomatic patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia underwent intravascular ultrasound imaging of the left anterior descending coronary, left main coronary and common iliac arteries. Angiography showed only minimal or no narrowing in these vessels. Intravascular ultrasound images obtained during catheter pullback underwent morphometric analysis. Plaque burden was expressed as the mean and maximal intimal index (ratio of plaque area and area within the internal elastic lamina) and as the percent of vessel surface covered by plaque. RESULTS Intravascular ultrasound detected plaque more frequently than angiography in the left anterior descending (80% vs. 29%, respectively), left main (44% vs. 16%) and iliac arteries (33% vs. 27%). Plaque burden was higher in the left anterior descending (mean intimal index [+/- SD] 0.25 +/- 0.16) than in the left main (0.11 +/- 0.16, p < 0.001) and iliac arteries (0.02 +/- 0.04, p < 0.001). Angiography detected lumen narrowing only in coronary arteries with a maximal intimal index > or = 0.42 (left anterior descending artery) and > or = 0.43 (left main artery). The area within the internal elastic lamina increased with plaque area in the left anterior descending (r = 0.82, p < 0.001) and left main arteries (r = 0.53, p < 0.001). By stepwise multiple regression analysis, the strongest predictor for plaque burden in the left anterior descending artery was the level of high density lipoprotein (HDL) cholesterol and total/HDL cholesterol ratio for the left main artery. CONCLUSIONS In patients with heterozygous familial hypercholesterolemia and familial combined hyperlipidemia, extensive coronary plaque is present despite minimal or no angiographic changes. Compensatory vessel enlargement and diffuse involvement with eccentric plaque may account for the lack of angiographic changes. Levels of HDL cholesterol and total/HDL cholesterol ratio are far more powerful predictors of coronary plaque burden than are low density lipoprotein cholesterol levels in these patients with early, asymptomatic disease.

[1]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[2]  J. Huttunen,et al.  Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. , 1988, JAMA.

[3]  Myers Lh,et al.  Mathematical evaluation of methods for estimation of the concentration of the major lipid components of human serum lipoproteins. , 1976 .

[4]  D. Thelle,et al.  THE TROMSØHEART-STUDY HIGH-DENSITY LIPOPROTEIN AND CORONARY HEART-DISEASE: A PROSPECTIVE CASE-CONTROL STUDY , 1977, The Lancet.

[5]  P. Yock,et al.  Increased prevalence of coronary ectasia in heterozygous familial hypercholesterolemia. , 1995, Circulation.

[6]  W. Roberts,et al.  Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. , 1979, Annals of internal medicine.

[7]  A J Tajik,et al.  Intravascular ultrasound imaging: in vitro validation and pathologic correlation. , 1990, Journal of the American College of Cardiology.

[8]  D. Gordon,et al.  High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial. , 1986, Circulation.

[9]  R. Frye,et al.  Association of Risk Factor Variables and Coronary Artery Disease Documented with Angiography , 1981, Circulation.

[10]  Fausto J. Pinto,et al.  Intravascular ultrasound imaging of coronary arteries. Is three layers the norm , 1991 .

[11]  J. H. Eusterman,et al.  Atherosclerotic Disease of the Coronary Arteries: A Pathologic‐Radiologic Correlative Study , 1962 .

[12]  E. Weibel.  Stereological Methods. Practical methods for biological morphometry , 1979 .

[13]  R. F. Donaldson,et al.  Attenuation of the media of coronary arteries in advanced atherosclerosis. , 1986, The American journal of cardiology.

[14]  J J Albers,et al.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. , 1990, The New England journal of medicine.

[15]  W. Roberts,et al.  Coronary artery imaging with intravascular high-frequency ultrasound. , 1990, Circulation.

[16]  P. Lichtlen,et al.  [The normal wall segment in coronary stenoses--a postmortal study (author's transl)]. , 1981, Zeitschrift fur Kardiologie.

[17]  S. Azen,et al.  Effects of colestipol-niacin therapy on human femoral atherosclerosis. , 1991, Circulation.

[18]  M. Bond,et al.  A study of atherosclerosis regression in Macaca mulatta. IV. Changes in coronary arteries from animals with atherosclerosis induced for 19 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dl. , 1981, Experimental and molecular pathology.

[19]  C. Zarins,et al.  Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.

[20]  J P Kane,et al.  Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Kunitake,et al.  Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities. , 1992, Journal of lipid research.

[22]  P. Serruys,et al.  The angle of incidence of the ultrasonic beam: a critical factor for the image quality in intravascular ultrasonography. , 1993, American heart journal.

[23]  R Erbel,et al.  The safety of intracoronary ultrasound. A multicenter survey of 2207 examinations. , 1995, Circulation.

[24]  L. Solberg,et al.  Risk Factors and Raised Atherosclerotic Lesions in Coronary and Cerebral Arteries , 1981, Arteriosclerosis.

[25]  R. Havel,et al.  Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia. , 1977, Journal of lipid research.

[26]  J. Griffith,et al.  Intravascular ultrasound cross-sectional arterial imaging before and after balloon angioplasty in vitro. , 1989, Circulation.

[27]  G. Watts,et al.  Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS) , 1992, The Lancet.

[28]  R. Kerber,et al.  Delineation of the extent of coronary atherosclerosis by high-frequency epicardial echocardiography. , 1987, The New England journal of medicine.

[29]  J. Tobis,et al.  Morphological Effects of Coronary Balloon Angioplasty In Vivo Assessed by Intravascular Ultrasound Imaging , 1992, Circulation.

[30]  W. Roberts,et al.  Accuracy of Angiographic Determination of Left Main Coronary Arterial Narrowing: Angiographic‐Histologic Correlative Analysis in 28 Patients , 1981, Circulation.

[31]  M. Marcus,et al.  Structural and Hemodynamic Responses of Peripheral Arteries of Macaque Monkeys to Atherogenic Diet , 1985, Arteriosclerosis.

[32]  A. Gotto,et al.  CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography , 2022 .

[33]  A. Zinsmeister,et al.  Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. , 1983, The New England journal of medicine.

[34]  M J Malloy,et al.  Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. , 1990, JAMA.

[35]  N. Morton,et al.  Sinking pre-beta lipoprotein and coronary heart disease in Japanese-American men in Hawaii. , 1978, American journal of epidemiology.

[36]  Gerald S. Berenson,et al.  Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa heart study , 1986 .

[37]  C T Lancée,et al.  Arterial wall characteristics determined by intravascular ultrasound imaging: an in vitro study. , 1989, Journal of the American College of Cardiology.

[38]  S. Isomura,et al.  CONTACT INFECTION FROM LIVE VARICELLA VACCINE RECIPIENTS , 1976, The Lancet.

[39]  S. Azen,et al.  Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up. , 1990, JAMA.

[40]  J. Schofer,et al.  Impact of compensatory enlargement of atherosclerotic coronary arteries on angiographic assessment of coronary artery disease. , 1989, Circulation.

[41]  N G Pandian,et al.  Ultrasound angioscopy: real-time, two-dimensional, intraluminal ultrasound imaging of blood vessels. , 1988, The American journal of cardiology.

[42]  B. Bulkley,et al.  The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease. , 1979, American journal of epidemiology.

[43]  J. Glomset,et al.  The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.